Quebec, Canada, February 1, 2012 – ABB, the leading power and automation technology group, announces the introduction of the new MB-Rx in-situ Reaction Monitor for research laboratories and pilot plants in the chemical, petrochemical, pharmaceutical and biopharmaceutical industries.
The MB-Rx is a plug-and-play solution designed around the key concepts of analytical performance, reliability and simplicity. This robust analyzer provides real-time insight into chemical reaction dynamics. Key parameters such as kinetics over different phases, reagent consumption and the synthesis of products and by-products can be assessed in real time.
The MB-Rx features a rugged Hastelloy ATR probe and an intuitive software interface that also allows for rapid set-up of experiment templates. The analyzer’s compact footprint allows it to fit inside crowded fume hoods, providing convenient access to reactors. Permanently aligned optics and a light source with an average lifespan of 10 years make the MB-Rx virtually maintenance-free. In addition, it does not use hygroscopic optics or a cryogenic detector, thus eliminating the need for optical purging, desiccant cartridges, liquid nitrogen or Stirling coolers.
'ABB introduces the new MB-Rx for in-situ reaction monitoring'
Sugary Namwhan